n-methyl-3,4-methylenedioxyamphetamine has been researched along with Dyskinesia, Medication-Induced in 6 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beaudoin-Gobert, M | 1 |
| Météreau, E | 1 |
| Duperrier, S | 1 |
| Thobois, S | 1 |
| Tremblay, L | 1 |
| Sgambato, V | 1 |
| Huot, P | 1 |
| Johnston, TH | 1 |
| Lewis, KD | 1 |
| Koprich, JB | 1 |
| Reyes, MG | 1 |
| Fox, SH | 1 |
| Piggott, MJ | 1 |
| Brotchie, JM | 1 |
| Panos, JJ | 1 |
| Baker, LE | 1 |
| Lettfuss, NY | 1 |
| Fischer, K | 1 |
| Sossi, V | 1 |
| Pichler, BJ | 1 |
| von Ameln-Mayerhofer, A | 1 |
| Iravani, MM | 1 |
| Jackson, MJ | 1 |
| Kuoppamäki, M | 1 |
| Smith, LA | 1 |
| Jenner, P | 1 |
| Bishop, C | 1 |
| Taylor, JL | 1 |
| Kuhn, DM | 1 |
| Eskow, KL | 1 |
| Park, JY | 1 |
| Walker, PD | 1 |
6 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates.
Topics: Animals; Brain; Diffusion Tensor Imaging; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug- | 2018 |
Characterization of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers in vitro and in the MPTP-lesioned primate: R-MDMA reduces severity of dyskinesia, whereas S-MDMA extends duration of ON-time.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Brain; Callithrix; Dyskinesia | 2011 |
Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats.
Topics: Animals; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Conditioning, Operan | 2012 |
Imaging DA release in a rat model of L-DOPA-induced dyskinesias: a longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Male; N- | 2012 |
3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Calli | 2003 |
MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dose-Respons | 2006 |